↓ Skip to main content

Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell…

Overview of attention for article published in European Journal of Cancer (1965), December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
101 Mendeley